A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis

NCT05919082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

604

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Plaque Psoriasis

Interventions

DRUG: LEO 90100
DRUG: Daivobet® ointment

Sponsor

LEO Pharma